Mark Massaro
Stock Analyst at BTIG
(4.51)
# 281
Out of 5,055 analysts
166
Total ratings
54.73%
Success rate
20.24%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Maintains: Buy | $6 → $7 | $3.21 | +118.07% | 9 | Nov 13, 2025 | |
| ZTS Zoetis | Maintains: Buy | $200 → $160 | $118.80 | +34.68% | 3 | Nov 12, 2025 | |
| PSNL Personalis | Maintains: Buy | $11 → $12 | $7.48 | +60.43% | 3 | Nov 11, 2025 | |
| XGN Exagen | Maintains: Buy | $13 → $15 | $8.47 | +77.10% | 5 | Nov 10, 2025 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $6 → $7 | $4.05 | +72.84% | 3 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Buy | $210 → $230 | $206.04 | +11.63% | 15 | Nov 7, 2025 | |
| CDNA CareDx | Maintains: Buy | $22 → $25 | $15.51 | +61.19% | 5 | Nov 6, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $19 → $21 | $13.71 | +53.17% | 7 | Nov 6, 2025 | |
| TEM Tempus AI | Reiterates: Buy | $96 | $66.39 | +44.60% | 5 | Nov 5, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $32 → $38 | $33.95 | +11.93% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $85 | $67.15 | +26.58% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $785 → $830 | $669.00 | +24.07% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $100 | $96.48 | +3.65% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $165 | $129.55 | +27.36% | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.07 | +133.64% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $9 | $7.78 | +15.68% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.63 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.50 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $10.22 | +105.48% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.28 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.53 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $120.08 | +149.83% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $74.14 | -32.56% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $186.19 | -39.85% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $261.37 | -36.87% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $21.10 | +279.15% | 9 | Sep 10, 2018 |
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $3.21
Upside: +118.07%
Zoetis
Nov 12, 2025
Maintains: Buy
Price Target: $200 → $160
Current: $118.80
Upside: +34.68%
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $7.48
Upside: +60.43%
Exagen
Nov 10, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $8.47
Upside: +77.10%
SOPHiA GENETICS
Nov 10, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $4.05
Upside: +72.84%
Natera
Nov 7, 2025
Maintains: Buy
Price Target: $210 → $230
Current: $206.04
Upside: +11.63%
CareDx
Nov 6, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $15.51
Upside: +61.19%
Adaptive Biotechnologies
Nov 6, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $13.71
Upside: +53.17%
Tempus AI
Nov 5, 2025
Reiterates: Buy
Price Target: $96
Current: $66.39
Upside: +44.60%
Castle Biosciences
Nov 5, 2025
Maintains: Buy
Price Target: $32 → $38
Current: $33.95
Upside: +11.93%
Nov 4, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $67.15
Upside: +26.58%
Nov 4, 2025
Maintains: Buy
Price Target: $785 → $830
Current: $669.00
Upside: +24.07%
Oct 30, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $96.48
Upside: +3.65%
Oct 29, 2025
Maintains: Buy
Price Target: $140 → $165
Current: $129.55
Upside: +27.36%
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.07
Upside: +133.64%
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $7.78
Upside: +15.68%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $10.22
Upside: +105.48%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.28
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.53
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $120.08
Upside: +149.83%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $74.14
Upside: -32.56%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $186.19
Upside: -39.85%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $261.37
Upside: -36.87%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $21.10
Upside: +279.15%